October 2019 FDA Recall Drug by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center
D-0154-2020 - Incorrect labeling
This Class III drug recall was voluntarily initiated by Nephron Pharmaceuticals Corporation Dba Nephron Sterile Compounding Center on October 21, 2019 for the product Drug. The FDA reported the reason for recall as incorrect labeling. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-0154-2020
Incorrect labeling: Incorrect or missing lot and/or exp date
10-21-2019
11-06-2019
19,390 syringes
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide in the U.S.
05-07-2020
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, Single-Dose Container, 5 x 10 mL pre-filled syringes, Nephron 503B Outsourcing Facility 4500 12th St. Ext West Columbia, SC 29172, NDC 69374-919-10.
Batch or Lot Expiration Information
Lot# Lots: SU9079A, SU9079B, Exp 4/5/2020